Onco Wiki / Indication

Juvenile myelomonocytic leukemia (JMML) · line 1 · Allogeneic hematopoietic cell transplant pathway for JMML

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Line of therapy1
Tracktransplant
Linked regimenREG-ALLOHCT-JMML
IDIND-JMML-1L-ALLOHCT
TypeIndication
Statusreviewed 2026-05-11
DiseasesDIS-JMML
SourcesSRC-COG

Notes

Coverage-enabling stub for DIS-JMML. Requires pediatric hematology and transplant co-lead signoff before clinical publication.

Used By

Algorithms